Posted Dec. 19, 2013 at 12:02 p.m.

Premium Lock On ending pharma payments to docs, GSK stands alone

Published: 2013-12-19 12:02:36
Updated: 2013-12-19 12:02:36

Andrew Witty    Andrew Witty. (GSK photo) Image 1 of 2 · Next Image…

Doctors prefer to learn about treatment options from their peers, and payments make sense given the time and energy required to understand and share information, according to companies that plan to keep remunerating physicians....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

page 1
sort order: oldest first | newest first
Don't count on it as big pharma will find another illegal way to sell more of their drugs.

Unfortunately as Big Pharma appears to be a corrupt system of doing business with all the multi-billion dollar out-of-court fines over the past few years, leopards never change their spots as history has shown. Indeed even the WHO appears to be controlled in many ways by BIG Pharma who have their researchers in prominent positions as advisers et al to the WHO. The 2009 so-called ‘Swine Flu’ pandemic is a prime example here where WHO advisers who were paid by the vast pharmaceutical industry ($770 billion of sales last year) persuaded the WHO to call a pandemic so that it would release tens of billions in drug sales (a sizable percentage ended up being destroyed because the stockpile became out of date).

But there are also so-called trusted science magazines that support Big pharma’s underhanded operations –
page 1
sort order: oldest first | newest first

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners


Frank Vinluan
Life science
Vivek Wadhwa
Dr. Mike Walden
Tech economy